Michael A. Treska

Mergers & Acquisitions

• Playtika in its US$2.2 billion IPO and acquisition of Wooga, a Germany-based developer of online mobile game applications
• William Lyon Homes in its US$2.4 billion sale to Taylor Morrison Home Corporation and US$520 million acquisition of Polygon Northwest Homes
• Advantage Solutions in its US$5.2 billion business combination with Conyers Park II Acquisition Corp.
• PDL BioPharma in its US$52.8 million divestiture of the Noden Pharmaceutical business to Stanley Capital
• Golden State Foods in its sale of nine distribution centers to The Martin-Brower Company
• Impact Biomedicines in its US$7 billion acquisition by Celgene Corporation
• Capella Education Company in its US$1.9 billion merger with Strayer Education, Inc.
• NYX Gaming in its US$631 million acquisition by Scientific Gaming
• Caesars Interactive Entertainment in its US$4.4 billion sale of its social and mobile games business, Playtika, to a consortium including Shanghai Giant Network Technology Co., Ltd.
• Thoratec in its US$3.4 billion acquisition by St. Jude Medical
• 5.11 Tactical in its US$400 million sale to Compass Diversified Holdings
• NextGen in its upsized US$230 million convertible senior notes offering
• QSI in its US$190 million acquisition of Health Fusion Holdings
• Fox Head in its US$195 million sale to Altamont Capital Partners
• Goldman Sachs in the US$7 billion acquisition of Amylin Pharmaceuticals by Bristol-Myers Squibb
• Quest Software in its US$2.4 billion acquisition by Dell
• Beckman Coulter, Inc. in its US$6.8 billion sale to Danaher
• Volcom in its US$600 million sale to PPR S.A.
• Beckman Coulter, Inc. in its ¥76 billion acquisition of a Japanese lab-based diagnostic system
• Harrah’s Entertainment, Inc. in its acquisition of Caesars Entertainment, Inc. and its issuance of US$3 billion of senior notes
• Oakley, Inc. in its acquisitions of Oliver Peoples, Inc., Optical Shop of Aspen, and Eye Safety Systems, Inc.

Capital Markets

• Tilly's in connection with its IPO
• Skilled Healthcare Group in connection with its IPO and its US$200 million senior subordinated notes offering

Healthcare & Life Sciences

• Allergan in the US$53 billion hostile takeover attempt by Valeant Pharmaceuticals International and Pershing Square
• Allergan in its US$73 billion sale to Actavis
• Goldman Sachs in the US$7 billion acquisition of Amylin Pharmaceuticals by Bristol-Myers Squibb
• PDL BioPharma in its US$52.8 million divestiture of the Noden Pharmaceutical business to Stanley Capital

Betting & Gaming

• Caesars Entertainment in its acquisition of a majority interest in Playtika Ltd., an Israeli social game developer
• Playtika in its US$2.2 billion IPO and acquisition of Seriously Holding Corp.
• NYX Gaming in its US$631 million acquisition by Scientific Gaming